Support energy and long-term wellness with science-informed care

The term is sometimes used to describe certain naturally occurring or laboratory-made peptides that researchers are studying for possible effects on biological processes related to metabolism, cellular signaling, tissue repair, recovery, and hormone pathways. Most of these substances are investigational. A small number of peptide medications are FDA-approved for specific medical conditions, but none are approved as general “anti-aging” or “longevity” treatments. Any discussion of these compounds should be understood in the context of ongoing research rather than established therapies.

Different peptides act on different biological pathways. Some are investigated for their potential to influence the body’s natural growth-hormone signaling; others are examined for effects on mitochondrial function, metabolic regulation, tissue repair, or cellular communication. Much of the available data comes from laboratory, animal, or early-stage human research. These compounds are not substitutes for hormones or lifestyle measures, and their long-term effects in healthy people seeking general wellness benefits remain incompletely understood.

Scientists continue to explore whether certain peptides may eventually play a role in areas such as cellular energy metabolism, recovery from physical stress, metabolic health markers, or aspects of healthy aging. At present, no peptide has been shown to stop, reverse, or reliably slow the aging process in humans. Results from research settings vary, and findings cannot be assumed to translate into everyday benefits for individuals.

These compounds act through different biological pathways. NAD+ is studied in relation to cellular energy metabolism, glutathione in relation to antioxidant systems, and Sermorelin in relation to growth-hormone signaling. Whether any combination is appropriate for a specific person is a clinical decision that can only be made by a licensed healthcare provider after reviewing medical history, current medications, laboratory results, and individual circumstances. Self-directed combination use is not recommended.

People sometimes ask clinicians about research related to energy, recovery, metabolic health, or healthy aging. A licensed healthcare provider is the appropriate person to evaluate whether any evidence-based medical approach (including approved medications when indicated) is suitable. Interest in general wellness optimization alone does not automatically mean a particular compound is appropriate or available.

All biologically active substances carry potential risks as well as possible benefits. Investigational and compounded peptides have not undergone the same level of FDA review for safety, effectiveness, and quality as approved drugs. Any use should occur only under the supervision of a licensed healthcare provider who can assess suitability, discuss known risks, and provide monitoring. Safety profiles differ by compound, dose, individual health status, and other factors.

Approval status varies by specific substance and intended use. Some peptide medications are FDA-approved for particular medical conditions. Many substances discussed in longevity or wellness contexts are not FDA-approved for those purposes. Compounded versions are prepared for individual patients under a prescription and are not FDA-approved as finished drug products. Investigational peptides such as MOTS-C have not been approved by the FDA for therapeutic use.

Timelines observed in research settings differ widely by compound, dose, study population, and endpoints measured. Some studies report changes in certain markers within weeks; other outcomes, when observed, develop over longer periods and usually in combination with lifestyle factors. Individual responses cannot be predicted, and no outcome is guaranteed.